- Home
- ORIC vs LSAK Comparison
ORIC vs LSAK Comparison
Compare ORIC & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- LSAK
- Stock Information
- Founded
- ORIC 2014
- LSAK 1997
- Country
- ORIC United States
- LSAK South Africa
- Employees
- ORIC N/A
- LSAK N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- LSAK Investment Bankers/Brokers/Service
- Sector
- ORIC Health Care
- LSAK Finance
- Exchange
- ORIC Nasdaq
- LSAK Nasdaq
- Market Cap
- ORIC 362.9M
- LSAK 408.0M
- IPO Year
- ORIC 2020
- LSAK N/A
- Fundamental
- Price
- ORIC $5.08
- LSAK $4.30
- Analyst Decision
- ORIC Strong Buy
- LSAK
- Analyst Count
- ORIC 8
- LSAK 0
- Target Price
- ORIC $18.83
- LSAK N/A
- AVG Volume (30 Days)
- ORIC 630.2K
- LSAK 22.6K
- Earning Date
- ORIC 05-05-2025
- LSAK 05-07-2025
- Dividend Yield
- ORIC N/A
- LSAK N/A
- EPS Growth
- ORIC N/A
- LSAK N/A
- EPS
- ORIC N/A
- LSAK N/A
- Revenue
- ORIC N/A
- LSAK $574,080,000.00
- Revenue This Year
- ORIC N/A
- LSAK $0.04
- Revenue Next Year
- ORIC N/A
- LSAK $1.74
- P/E Ratio
- ORIC N/A
- LSAK N/A
- Revenue Growth
- ORIC N/A
- LSAK 4.13
- 52 Week Low
- ORIC $3.90
- LSAK $3.39
- 52 Week High
- ORIC $14.67
- LSAK $5.60
- Technical
- Relative Strength Index (RSI)
- ORIC 44.71
- LSAK 43.32
- Support Level
- ORIC $4.52
- LSAK $3.39
- Resistance Level
- ORIC $5.83
- LSAK $4.53
- Average True Range (ATR)
- ORIC 0.52
- LSAK 0.30
- MACD
- ORIC 0.07
- LSAK -0.03
- Stochastic Oscillator
- ORIC 40.58
- LSAK 66.91
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.